1. Dr Reddy’s buys 6 OTC brands from US-based Ducere Pharma

Dr Reddy’s buys 6 OTC brands from US-based Ducere Pharma

Drug major Dr Reddy's Laboratories has forayed into branded consumer health products segment in the US market by acquiring six over-the-counter (OTC) brands from Ducere Pharma for an undisclosed amount.

By: | New Delhi | Published: May 25, 2016 6:38 PM
"We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US," Executive Vice-President and Head of Dr Reddy's in the US Alok Sonig said. (PTI) “We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US,” Executive Vice-President and Head of Dr Reddy’s in the US Alok Sonig said. (PTI)

Drug major Dr Reddy’s Laboratories has forayed into branded consumer health products segment in the US market by acquiring six over-the-counter (OTC) brands from Ducere Pharma for an undisclosed amount.

The brands acquired include Doan’s, Bufferin, Nupercainal ointment, Cruex nail gel, comtrex and myoflex. These are mainly used in treating cough-and-cold, pain and dermatology issues.

“We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US,” Executive Vice-President and Head of Dr Reddy’s in the US Alok Sonig said.

These legacy products enjoy strong brand equity built over several decades, he added.

Dr Reddy’s will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new market channels, Sonig said.

Dr Reddy’s shares today ended 0.92 per cent higher at Rs 3,052.95 apiece on BSE.

Get latest news and updates on Auto Expo 2018, check breaking news on Budget 2018, like us on Facebook and follow us on Twitter.

  1. No Comments.

Go to Top